January 18, 2016
A deadly fungal lung infection that affects transplant or leukaemia patients could soon be treated faster thanks to a new test developed by British scientists.
Up to a quarter of all patients who have had a bone marrow, heart or lung transplant, or high-dose chemotherapy for leukaemia are affected by invasive pulmonary aspergillosis.
...The new test involves attaching radioactively labeled antibodies to the infecting structures formed by the growing fungus, making it visible to doctors.
It uses a combination of PET and MRI imaging, diagnostic technologies present in many hospitals, to identify the disease and to rule out lung infections caused by other pathogens such as bacteria or viruses.
Read the full article.